StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) income statement

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.69−0.04 (-5.27%)

Close on Nov 20, 2026Market cap $30.91MP/E –Yield –

TELA Bio, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
67.8%
Operating margin
-42.6%
Net margin
-51.5%
Return on equity, FY2025
-223.4%

Financial strength

Current ratio
2.99
Debt to equity
-3.53
Debt to assets
93.9%
Cash to current liabilities
167.0%

Valuation

P/E ratio
–
Price to sales
0.39
Price to book
–
Dividend yield
–

See a number that looks wrong?